
Review the recommendations for the wearable cardioverter defibrillator (WCD), as well as additional guidelines for the care of patients at risk for sudden cardiac death (SCD).
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 1
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2 The WCD may be considered in the early phase after MI in selected patients.
ZOLL is ready to assist you in meeting your care goals. The team that has protected globally 1M+ LifeVest patients over 20+ years now provides a suite of solutions. Connect with an expert for personalised support.
GET IN TOUCH